B. Riley Securities analyst Kara Anderson maintains Spark Networks (NASDAQ:LOV) with a Buy and lowers the price target from $6 to $3.
DiaMedica Therapeutics Q2 EPS $(0.13) Beats $(0.18) Estimate
DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.18) by 27.78 percent. This is a 23.53 percent increase over losses of $(0.17) per share